Stroke is one of the leading causes of death and disability around the world. It often happens suddenly and can leave people with long-term problems such as weakness, speech difficulties, or memory loss.
Many strokes are caused by blood clots that block blood flow to the brain. Because of this, doctors are always looking for better ways to prevent clots before they cause serious harm.
A new study has found that a common blood thinner called apixaban may help prevent strokes in people with a hidden heart condition that often goes unnoticed.
This condition is called sub-clinical atrial fibrillation, or SCAF. The findings could change how doctors treat people who are at risk, especially as more people are being diagnosed with this silent condition.
Atrial fibrillation is a type of irregular heartbeat. In many cases, it can cause symptoms such as a racing heart, dizziness, or shortness of breath. However, in SCAF, the condition does not cause obvious symptoms.
People may feel completely normal and not know anything is wrong. Because of this, SCAF is often only discovered through special heart monitors, such as implanted devices or wearable technology.
Even though it is silent, SCAF can still be dangerous. The irregular heartbeat can cause blood to move unevenly through the heart, which increases the chance of forming blood clots. These clots can travel to the brain and cause a stroke. This makes early detection and treatment very important.
The new study was led by Dr. Jeff Healey from the Population Health Research Institute. It followed more than 4,000 people from 16 different countries over a period of eight years. All of the participants had SCAF and were at risk of stroke. The researchers wanted to find out whether apixaban could reduce this risk.
Apixaban is a widely used medication that helps prevent blood from clotting too easily. It is already used to reduce the risk of stroke in people with known atrial fibrillation. In this study, researchers tested whether it could also help people with the hidden form of the condition.
The results were very encouraging. People who took apixaban had a much lower risk of stroke or blood clots compared to those who did not take the drug.
The risk was reduced by about 37 percent. Even more importantly, the number of fatal or disabling strokes was reduced by nearly half. This suggests that the drug not only lowers the risk but may also prevent the most serious outcomes.
Like all medications, apixaban does have some risks. The study found that it increased the chance of major bleeding. However, most of these bleeding events were not fatal and could be treated. This means that for many patients, the benefits of preventing a stroke may be greater than the risks.
The findings from this study were published in the New England Journal of Medicine and were also presented at the American Heart Association Scientific Sessions. Because the study was large and lasted for many years, it provides strong evidence that could influence future treatment guidelines.
This research is especially important today because more people are using wearable devices such as smartwatches that can detect irregular heart rhythms.
These devices are helping doctors find hidden conditions like SCAF much earlier than before. With earlier detection, it may be possible to start treatment sooner and prevent strokes before they happen.
The study also highlights a shift in how doctors think about prevention. Instead of waiting for symptoms to appear, there is growing interest in treating conditions at an earlier stage, even when they are silent. This approach could save lives and reduce the burden of stroke on individuals and healthcare systems.
For people who may be at risk, this research is a reminder of the importance of regular health checks and monitoring. It also shows how advances in both medicine and technology are working together to improve care.
In the future, treatments like apixaban may become more widely used for people with hidden heart rhythm problems. However, decisions about medication should always be made with a doctor, who can consider each person’s health and risk factors.
This study offers hope that with better detection and the right treatment, many strokes could be prevented. It shows that even a silent condition can be managed effectively when it is found early and treated in the right way.
If you care about stroke, please read studies about how to eat to prevent stroke, and diets high in flavonoids could help reduce stroke risk.
For more health information, please see recent studies about how Mediterranean diet could protect your brain health, and wild blueberries can benefit your heart and brain.
Copyright © 2026 Knowridge Science Report. All rights reserved.
